Molecular Formula : CHNOCu CAS Number: 49557-75-7 In the absence of copper, the peptide exists as GHK, which exhibits substantially reduced biological activity
The method of claim 12, wherein said one or more HGF mimics is administered in the form of a pharmaceutically acceptable salt
Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis
CAT No: CPC1613 CAS No: 89030-95-5 Synonyms/Alias: Prezatide copper;GHK copper;89030-95-5;CG-copper peptide;Copper tripeptide-1;Oristar Cu-GHK;UNII-6BJQ43T1I9;Copper tripeptide;6BJQ43T1I9;copper;(2S)-6-amino-2-[[(2S)-2-[(2-aminoacetyl)amino]-3-(1H-imidazol-5-yl)propanoyl]amino]hexanoate;DTXSID20237492;Copper, (N2-(N-glycyl-L-histidyl)-L-lysinato(2-))-;Copper, (glycyl-kappaN-L-histidyl-kappaN,kappaN3-L-lysinato(2-))-;GHK-Cu;[N2-(N-Glycyl-L-histidyl)-L-lysinato(2-)]copper;Copper tripeptide-1 [INCI];Mask Pack;Copper tripeptide?;Copper Tripeptide 1;Copper tripeptide-1.xHOAc;Skin Delight Mask Pack Plus;DTXCID20159983;Copper peptide(GHK-Cu) TFA salt;Copper Tripeptide-1 (0.001%);Dermaheal Skin Delight Mask Pack Plus;DB14683;FC138108;FC180071;Glycyl-histidyl-lysine monocopper TFA salt;Copper Peptide pound 1:1 pound(c) Acetate;NEWSTEM Rx FRACTIONAL REPAIR Energy Ampoule;A936552;Q27264447
They do not cause dependency and do not sedate the brain the way sleep medications do
The consensus among conservative, evidence-driven physicians is that BPC-157 should only be used, if at all, in controlled research settings until its safety is definitively proven
